By avoiding these foods, you can minimise side effects and maximise the benefits of your GLP-1 therapy
Probiotics Supporting Gut Health and Digestive Comfort Why it matters: GLP-1 medications alter gut motility, which can disrupt the microbiome and trigger symptoms like bloating, diarrhea, and digestive discomfort, particularly in the early weeks of treatment
BMI is an important factor, but it is only one part of the overall assessment
As shown in Figure 2 , the time of AKI caused by different GLP-1RA was calculated as follows: median time of lixisenatide was 0 days, albiglutide was 151 days [interquartile range (IQR): 41.5-252 days], exenatide was 94 days [interquartile range (IQR): 30-664.75 days], dulaglutide was 14 days [interquartile range (IQR): 6-122.5 days], liraglutide was 62 days [interquartile range (IQR): 13-510 days], and semaglutide was 51 days [interquartile range (IQR): 14.75-163.2.5 days]